This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral structure makes it particularly valuable in the development of enantiomerically pure drugs, which often exhibit improved efficacy and reduced side effects compared to their racemic counterparts. It is commonly employed in the production of medications targeting the central nervous system, such as antidepressants and antipsychotics, due to its ability to interact with specific neurotransmitter receptors. Additionally, it serves as a building block in the creation of compounds with potential therapeutic applications in pain management and neurodegenerative diseases. Its versatility in organic synthesis also extends to research and development, where it is used to explore novel drug candidates and optimize pharmacological properties.